Showing 1 - 5 results of 5 for search 'Seyed Reza Mousavi (13223324)', tempo de consulta: 0.01s Limitar resultados
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. por Seyed Reza Mousavi (13223324)

    Publicado 2025
    Engadir a favoritos
    Gardado en:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. por Seyed Reza Mousavi (13223324)

    Publicado 2025
    Engadir a favoritos
    Gardado en:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. por Seyed Reza Mousavi (13223324)

    Publicado 2025
    Engadir a favoritos
    Gardado en:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. por Seyed Reza Mousavi (13223324)

    Publicado 2025
    Engadir a favoritos
    Gardado en:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. por Seyed Reza Mousavi (13223324)

    Publicado 2025
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: